Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers
EONN
2 other identifiers
interventional
130
1 country
1
Brief Summary
Night shift work schedules disrupt sleep and have a negative impact on cardiovascular health. Most who work in public safety occupations and in healthcare work night shifts. These workers experience abnormal blood pressure during night shifts and are at greater risk of cardiovascular disease. Napping during night shifts can help to restore blood pressure patterns to a more normal pattern and may help to reduce risk of cardiovascular disease. Naps may also have an impact on alertness and performance immediately upon waking. The overarching goal of this study is to determine which duration of a nap taken during simulated night shift work has the greatest impact blood pressure and post-nap performance. Researchers will compare 5 nap durations to see which has the greatest impact on blood pressure patterns and post-nap psychomotor performance. Researchers hypothesize that longer naps will lead to improved blood pressure outcomes and shorter naps will contribute to better performance after waking. Findings will help employers and employees who work night shifts determine how best to incorporate brief naps during night shift work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2025
CompletedFirst Posted
Study publicly available on registry
October 16, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2030
April 30, 2026
April 1, 2026
4.3 years
October 2, 2025
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
BP dipping
The ratio of mean sleep to mean wake blood pressure (BP) by taking the difference between the mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) during nap opportunities, and the mean SBP and DBP during wake periods.
During simulated night shift, 12 hours
Psychomotor performance post-nap
Severe psychomotor impairment post-nap as measured by the Psychomotor Vigilance Test Brief (PVT-B)
During simulated night shift, greater than or equal to 10 minutes post intervention nap
Secondary Outcomes (1)
Performance on simulated patient scenarios
During simulated night shift, 12 hours
Study Arms (1)
Napping order
OTHER5 x 4 x 3 x 2 = 120 possible orderings of the 5 interventions for each person.
Interventions
Eligibility Criteria
You may qualify if:
- non-pregnant adults (\>18 years of age)
- certified public safety/healthcare shift worker
- is an active shift worker
- resides within the Western Pennsylvania region within reasonable driving distance
You may not qualify if:
- current use of medication for cardiovascular disease (e.g., hypertension)
- prior or current diagnosis of sleep apnea, narcolepsy, restless leg syndrome, ischemic heart disease, heart failure, stroke, chronic kidney disease, chronic liver disease, rheumatologic disease requiring prescription medication, and cancer requiring treatment in past 2 years
- undiagnosed severe sleep apnea (Apnea-Hypopnea Index \>30) based on at-home test
- Abstains from caffeine or reports adverse effects from caffeine use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Patterson
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants are blinded to the nap duration.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 2, 2025
First Posted
October 16, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
August 31, 2030
Study Completion (Estimated)
August 31, 2030
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- No later than 3 years after completing the last follow-up of the last participant.
- Access Criteria
- Access through NHLBI BioLINCC repository
All collected IPD